Disclosure under Regulation 30 of SEBI ( LODR) Regulations, 2015
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements Requirements) Regulations, 2015.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Jun 26 2025
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release May 30 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Later from Vista Pharmaceuticals
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vista Pharmaceuticals Ltd. Press Release Jul 15 2025
- Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals